Effect of Hospital Pharmacist Collaboration on Solving Pharmacotherapy Problems in Stroke Patients with Changes in Medical Care Environment "Randomaized Controlled Trial"

Effect of Hospital Pharmacist Collaboration on Solving Pharmacotherapy Problems in Stroke Patients with Changes in Medical Care Environment "Randomaized Controlled Trial" - HCPC-Study-Stroke RCT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000051681

Enrollment

Registered

2023-07-24

Start date

2023-07-24

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Two-way sharing of patient infomation between hospital pharmacists and community pharmacists using online tools usual care (no sharing of patient infomation between hospital pharmacists and community

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with stroke (cerebral infarction) who transferred to convalescent wards after acute treatment and visit other hospitals

Exclusion criteria

Exclusion criteria: Patients who do not have family pharmacy at the time of admission Patients who was prescribed no medication at discharge Others who are deemed ineligible by the research director or research collaborators

Design outcomes

Primary

Measure	Time frame
Number of drugs for which discrepancies were resolved	—

Secondary

Measure	Time frame
Number of interventions	—

Countries

Japan

Contacts

Public ContactFukuda Yuko

JCHO Hoshigaoka Medical Center phaemaceutical department

fukuda-yuko@hoshigaoka.jcho.go.jp0728402641

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026

Effect of Hospital Pharmacist Collaboration on Solving Pharmacotherapy Problems in Stroke Patients with Changes in Medical Care Environment &quot;Randomaized Controlled Trial&quot;